仿制药肿瘤药物市场概况、增长、趋势、分析、研究报告(2021-2031 年)

  • Report Code : TIPRE00006393
  • Category : Life Sciences
  • No. of Pages : 150
Buy Now

仿制药肿瘤药物市场规模预计在 2022 年为 247.8 亿美元,在 2023 年为 XX 亿美元,预计到 2031 年将达到 424.3 亿美元;预计到 2031 年的复合年增长率将达到 6.3%。政府针对癌症治疗的举措很可能仍是仿制药肿瘤药物市场的主要趋势。

 

仿制肿瘤药物市场分析

根据 VOXEU 发布的一份报告,由于全球医疗预算面临压力,改用品牌仿制药似乎是一种自然的成本节约方式。肿瘤仿制药是品牌药物的廉价替代品,可为任何医疗保健系统带来效率提升。随着肿瘤药物渠道的缩减和许多肿瘤药物专利即将到期,肿瘤仿制药的生产迅速增加。

仿制药在肿瘤学中很重要,因为一些抗癌药物仅以仿制药的形式提供。在大多数情况下,例如患有急性淋巴细胞白血病的儿童或患有早期乳腺癌的女性患者都使用仿制药治疗。仿制药广泛用于支持性护理。使用仿制药的最大好处是成本,比品牌药低 85%。因此,仿制肿瘤药物的渗透率不断上升,推动了市场的增长。 

 

仿制肿瘤药物市场概况

科学电子图书馆在线 (SciELO) 报告指出,推广品牌仿制药是各国国家药品政策的核心手段,最终通过扩大医疗保健渠道减少药品支出。例如,为了以可承受的价格提供优质的仿制药,印度政府化学和化肥部制药司于 2008 年 11 月推出了 Pradhan Mantri Bhartiya Janaushadhi Pariyojana (PMBJP)。该计划专注于名为 Janaushadhi Kendras 的专卖店,以可承受的价格提供仿制药。截至 2021 年,全国共有 8,012 家 Janaushadhi Kendras 在运营。印度政府越来越重视提供用于治疗包括癌症在内的各种疾病的仿制药,这推动了印度仿制肿瘤药物市场的增长。

 

定制此报告以满足您的需求

您可以免费定制任何报告,包括本报告的部分内容、国家级分析、Excel 数据包,以及为初创企业和大学提供优惠和折扣

仿制药肿瘤药物市场:

Generic Oncology Drugs Market
  • 获取此报告的关键市场趋势。
    这个免费样品将包括数据分析,从市场趋势到估计和预测。

 

仿制药肿瘤药物市场驱动因素和机遇

 

癌症负担加重

癌症是全球主要死亡原因之一,极大地影响着生活质量。因此,如果不及时诊断和治疗,癌症将成为社会的负担。根据世界卫生组织 (WHO) 的数据,2022 年,诊断出约 2000 万例新癌症病例,约 970 万人死于癌症。根据同一来源,约有 5350 万人在癌症诊断后 5 年内存活。为了控制和管理癌症,各公司正专注于开发仿制肿瘤药物。因此,癌症患病率的增加和死于癌症的人数的增加正在推动仿制肿瘤药物市场的增长。

 

个性化医疗趋势——仿制药市场的机会

个性化医疗是一种新方法,但它是医疗保健领域一个发展迅速的领域,医生可以根据患者的基因特征选择治疗方法,这不仅可以最大限度地减少有害副作用,还可以在短时间内取得成功。癌症个性化医疗涉及研究个体肿瘤生长的基因组成。通过研究患者的基因组成,肿瘤学家可以根据患者的基因突变定制治疗方案。例如,ALK、KRAS 和 EGFR 突变会导致肺癌。然而,确定肺癌患者的突变类型为治疗类型提供了关键信息。在个性化医疗之前,所有患者都接受针对特定类型癌症的相同治疗。然而,随着个性化医疗的出现,患者根据其基因组成接受治疗。切除患者的组织以进行基因诊断过程。检查患者的组织样本是否存在基因突变,进一步根据突变类型进行化疗。这允许在正确的时间进行正确的治疗,从而降低死亡率。由于根据个人基因特征制定治疗方案的这些优势,个性化医疗方法可能会为仿制肿瘤药物市场创造许多机会。

 

仿制肿瘤药物市场报告细分分析

有助于得出仿制肿瘤药物市场分析的关键部分是解决方案、交付方式、应用和最终用户。

  • 根据分子类型,仿制肿瘤药物市场分为大分子和小分子。小分子部分在 2023 年占据了更大的市场份额。
  • By indication, the Generic Oncology Drugs Market is segmented into lung cancer, stomach cancer, colorectal cancer, breast cancer, prostate cancer, liver cancer, kidney cancer, cervical cancer, and others. The stomach cancer segment held the largest market share in 2023.

 

Generic Oncology Drugs Market Share Analysis by Geography

The geographic scope of the Generic Oncology Drugs Market report is mainly divided into five regions: North America, Asia Pacific, Europe, Middle East & Africa, and South & Central America.

North America has dominated the Generic Oncology Drugs Market. The demand for the market in the region is anticipated to witness growth at a significant rate during the forecast period owing to various factors such as, rising prevalence of cancer, along with increasing awareness regarding the medical condition as well as the presence of supportive associations in the region. Furthermore, the US government is opting for cheaper version of a brand-name drug, which is likely to influence the generic oncology drugs market.

 

 

Generic Oncology Drugs Market Regional Insights

The regional trends and factors influencing the Generic Oncology Drugs Market throughout the forecast period have been thoroughly explained by the analysts at Insight Partners. This section also discusses Generic Oncology Drugs Market segments and geography across North America, Europe, Asia Pacific, Middle East and Africa, and South and Central America.

Generic Oncology Drugs Market
  • Get the Regional Specific Data for Generic Oncology Drugs Market

Generic Oncology Drugs Market Report Scope

Report AttributeDetails
Market size in 2022US$ 24.78 Billion
Market Size by 2031US$ 42.43 Billion
Global CAGR (2023 - 2031)6.3%
Historical Data2021-2022
Forecast period2024-2031
Segments CoveredBy Molecular Type
  • Large Molecule
  • Small Molecule
By Indication
  • Lung Cancer
  • Stomach Cancer
  • Colorectal Cancer
  • Breast Cancer
  • Prostate Cancer
  • Liver Cancer
  • Kidney Cancer
  • Cervical Cancer
Regions and Countries CoveredNorth America
  • US
  • Canada
  • Mexico
Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • Teva Pharmaceutical Industries LTD.
  • Sandoz International GMBH
  • Glenmark Pharmaceuticals LIMITED
  • Sun Pharmaceutical Industries LTD
  • MSN Laboratories
  • Aurobindo Pharma
  • Intas Pharmaceuticals LTD
  • Zydus Cadila
  • Mylan N.V.
  • Shilpa Medicare LTD

 

Generic Oncology Drugs Market Players Density: Understanding Its Impact on Business Dynamics

The Generic Oncology Drugs Market market is growing rapidly, driven by increasing end-user demand due to factors such as evolving consumer preferences, technological advancements, and greater awareness of the product's benefits. As demand rises, businesses are expanding their offerings, innovating to meet consumer needs, and capitalizing on emerging trends, which further fuels market growth.

市场参与者密度是指在特定市场或行业内运营的企业或公司的分布情况。它表明在给定市场空间中,相对于其规模或总市场价值,有多少竞争对手(市场参与者)存在。

在仿制肿瘤药物市场运营的主要公司有:

  1. 梯瓦制药工业有限公司
  2. 山德士国际有限公司
  3. 格兰马克制药有限公司
  4. 太阳制药工业有限公司
  5. MSN 实验室
  6. 阿拉宾多制药公司

免责声明上面列出的公司没有按照任何特定顺序排列。


Generic Oncology Drugs Market

 

  • 了解仿制药市场的主要参与者概况

 

仿制药肿瘤药物市场新闻和最新发展

通过收集初级和二级研究后的定性和定量数据来评估仿制肿瘤药物市场,其中包括重要的公司出版物、协会数据和数据库。以下是神经介入设备和策略市场的发展列表:

  • Zydus Lifesciences 在印度以 IBYRA 为品牌推出了 PARP 抑制剂 olaparib,让所有人都能接受晚期癌症治疗。PARP(聚 ADP 核糖聚合酶)是一种帮助受损细胞自我修复的蛋白质。作为一种癌症治疗,PARP 抑制剂阻止 PARP 在癌细胞中进行修复工作,导致细胞死亡。(来源:《经济时报》,新闻稿,2024 年)
  • Gland Pharma 在美国市场推出了抗癌药物注射用硼替佐米。该公司已通过其合作伙伴在美国市场推出该产品,该产品已获得美国食品药品管理局的批准。(来源:《经济时报》,新闻稿,2022 年)

 

仿制药肿瘤药物市场报告覆盖范围和交付成果

“仿制肿瘤药物市场规模和预测(2021-2031 年)”报告对市场进行了详细分析,涵盖以下领域:

  • 范围内所有主要细分市场的全球、区域和国家层面的市场规模和预测
  • 市场动态,如驱动因素、限制因素和关键机遇
  • 未来的主要趋势
  • 详细的 PEST/波特五力分析和 SWOT 分析
  • 全球和区域市场分析涵盖关键市场趋势、主要参与者、法规和最新市场发展
  • 行业格局和竞争分析,涵盖市场集中度、热点图分析、知名参与者和最新发展
  • 详细的公司简介
  • Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
  • PEST and SWOT Analysis
  • Market Size Value / Volume - Global, Regional, Country
  • Industry and Competitive Landscape
  • Excel Dataset
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Trends and growth analysis reports related to Life Sciences : READ MORE..   
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.


Buy Now  

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.